Search PubMed⌕ Search

PubMed · 15939011

Clinical inquiries. Does digoxin decrease morbidity for those in sinus rhythm with heart failure?

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Charissa Fotinos, Joan Nashelsky. 2005. Clinical inquiries. Does digoxin decrease morbidity for those in sinus rhythm with heart failure?. https://pubmed.ncbi.nlm.nih.gov/15939011/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Atrioventricular nodal reentrant tachycardia in children.

The purpose of this study was to identify the clinical and electrophysiological characteristics of children with atrioventricular reentry tachycardia (AVNRT) and to define the prognosis and the treatment strategy. Sixty-two children (28 males and 34 females mean age, 10.2 +/- 3.2 years) with AVNRT ("slow-fast" type) were included in the study. Patients were divided into two groups: 47 patients with severe symptoms (group A) and 15 with mild symptoms (group B). The severity of the symptoms was not related to the electrophysiological parameters. Females were more symptomatic than males. Patients in group B did not receive any treatment (except 1 because of parents' choice) nor did they develop symptoms, and 5 patients had resolution of palpitations. Forty-one of 46 patients in group A were successfully treated with medical therapy as initial treatment. Thirty-one patients in group A underwent slow pathway ablation. There were late recurrences of AVNRT in 6 patients. Typical AVNRT in young patients does not appear to be life threatening. Patients with mild or no symptoms do well without therapy. Medical therapy and slow pathway ablation appear to be effective in the more symptomatic patients. Age and electrophysiological variables are not related to the symptoms or response to treatment. Females with AVNRT are more symptomatic and more likely to present with syncope.

Anti-Arrhythmia Agents↗

Successful parental use of an automated external defibrillator for an infant with long-QT syndrome.

Congenital long-QT syndrome with 2:1 atrioventricular block presenting in the perinatal period is rare, has a poor prognosis, and leads to high risk for lethal ventricular arrhythmic events. An implantable cardioverter-defibrillator seems to be the most effective treatment in the prevention of arrhythmic sudden cardiac death in patients with long-QT syndrome. Technical limitations and risks associated with implantable cardioverter-defibrillators in asymptomatic infants is considered too great to justify use for primary prophylaxis against sudden cardiac death. In this case report we describe the first successful parental use of an automated external defibrillator prescribed for primary prophylaxis against sudden cardiac death in an infant with long-QT syndrome.

Anti-Arrhythmia Agents↗